Compare ELVA & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVA | TMCI |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.2M | 292.0M |
| IPO Year | 2021 | 2021 |
| Metric | ELVA | TMCI |
|---|---|---|
| Price | $4.93 | $3.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $14.60 | $5.50 |
| AVG Volume (30 Days) | ★ 446.2K | 190.1K |
| Earning Date | 12-09-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | $10.18 | N/A |
| Revenue Next Year | $43.01 | $6.88 |
| P/E Ratio | $78.51 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $4.10 | $1.17 |
| 52 Week High | $12.78 | $5.25 |
| Indicator | ELVA | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 39.16 | 40.91 |
| Support Level | N/A | $3.82 |
| Resistance Level | $6.85 | $4.77 |
| Average True Range (ATR) | 0.33 | 0.38 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 33.67 | 25.96 |
Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.